IRAKIMID

View On IPO.GOV.UK

Registered

on 15 Feb 2022

Last Applicant/ Owned by

Kymera Therapeutics, Inc.

300 Technology Square, 2nd Floor

Cambridge, Massachusetts, 02139

Serial Number

UK00003754821 filed on 15^th Feb 2022

Registration Number

UK00003754821 registered on
13^th May 2022

Correspondent Information

Dechert LLP

160 Queen Victoria Street

London,

EC4V4QQ

IRAKIMID

pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medi Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases.

Mark Details

Serial Number

UK00003754821

Mark Type

Word

Kind of mark

Individual

IRAKIMID

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products